# Stefan Catsicas

> Stefan Catsicas is a seed investor at Skyviews Life Science backing Biotechnology and Medical. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Skyviews Life Science](https://shizune.co/investors/profile/skyviews-life-science)
- Location: Vevey, Switzerland
- Total investments: 2
- Last investment: Oct 2022
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/stefan-catsicas-317291175

Stefan Catsicas is a seed investor at Skyviews Life Science in Vevey focused on Biotechnology and Medical. Prof. Stefan Catsicas has been the Chief Technology Officer and Executive Vice President at Nestlé S.A. since September 1, 2013. Prof. Catsicas is the President and Founder at Tilocor Life Sciences. He was the Vice President at Polytechnique Fédérale de Lausanne. Prof. Catsicas was the Department Head and managed research and preclinical programsin Neurosciences at the Glaxo Institute for Molecular Biology and served as Professor and Chairman of Cellular Biology at the School of Medicine in Lausanne. He was then appointed the Vice-President and Research Director at the Swiss Federal Institute of Technology in Lausanne (EPFL) where he still holds the Chair of Cellular Engineering. In addition to his academic activities Prof. Catsicas has promoted and advised biotechnology companies in Europe and in the United States and has been an Advisor for investment funds such as the Pictet Biotech Fund. He is a Director of Therasis, Inc. and Eclosion SA. Prof. Catsicas received a Ph.D. in Neurosciences from the University of Lausanne and did postdoctoral work at the Research institute of Scripps Clinic.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 100% |
| Medical | 1 | 50% |
| Life Science | 1 | 50% |
| Manufacturing | 1 | 50% |
| Food and Beverage | 1 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 50% |
| Series A | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Volumina Medical | Volumina is active in the field of tissue engineering and develops injectable 3D scaffolds for the reconstruction of volumes of soft tissues (fat, muscles, glandular tissues, supporting and connective tissues) that have been lost after tumor ablation, disease, trauma, or for purely esthetically purposes. |  | Series A | Oct 04, 2022 |  |
| MIRAI FOODS | Mirai Foods is a cellular agriculture startup developing cultured beef. | $4.5M | Seed | Mar 15, 2021 |  |

2 of 2 investments shown.

## Co-investors
- [Clinique La Prairie](https://shizune.co/investors/profile/clinique-la-prairie) — VC Fund, 1 deal together
- [FRIBA Investment](https://shizune.co/investors/profile/friba-investment) — VC Fund, 1 deal together
- [PINC](https://shizune.co/investors/profile/pinc-0786) — VC Fund, 1 deal together
- [Team Global](https://shizune.co/investors/profile/team-europe-ventures) — VC Fund, 1 deal together
- [Yakumi](https://shizune.co/investors/profile/yakumi-investment) — VC Fund, 1 deal together

## About Skyviews Life Science

VC Fund · Lausanne, Switzerland

Skyviews Life Science is a privately held advisory company specializing in personalized health. Skyviews Life Science identifies investment opportunities in companies at the growing interface between biotechnology, advanced nutrition, and digital health.Skyviews Life Science focuses in private and public companies with better drugs, advancedtechnology platforms, preventive strategies, personalized solutions, and more natural foods that will improve people’s quality of life.

4 contacts available at Skyviews Life Science.

| Name | Title | Profile |
| --- | --- | --- |
| Boris F. J. Collardi | Founding investor | https://shizune.co/investors/profile/boris-f-j-collardi |
| Jean-Pierre Aoun | Co-Founder and General Partner | https://shizune.co/investors/profile/jean-pierre-aoun |
| R. Anthony Williamson | Partner Biotechnology and Health Science | https://shizune.co/investors/profile/r-anthony-williamson |
| Stefan Catsicas | Co-Founder and Managing Partner | https://shizune.co/investors/profile/stefan-catsicas |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Stefan Catsicas invest in?

Stefan Catsicas invests primarily in Biotechnology, Medical and Life Science startups, most often at Seed and Series A stage. Most of the 2 investments tracked by Shizune back companies in Switzerland. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Stefan Catsicas last invest?

The most recent investment recorded for Stefan Catsicas closed in Oct 2022. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co